Your browser doesn't support javascript.
loading
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Schernthaner, Guntram; Shehadeh, Naim; Ametov, Alexander S; Bazarova, Anna V; Ebrahimi, Fahim; Fasching, Peter; Janez, Andrej; Kempler, Péter; Konrade, Ilze; Lalic, Nebojsa M; Mankovsky, Boris; Martinka, Emil; Rahelic, Dario; Serafinceanu, Cristian; Skrha, Jan; Tankova, Tsvetalina; Visockiene, Zydrune.
Afiliación
  • Schernthaner G; Medical University of Vienna, Vienna, Austria. guntram@schernthaner.eu.
  • Shehadeh N; Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus and the Bruce Rappaport Faculty of Medicine, Technion, P.O. Box 9602, 3109601, Haifa, Israel.
  • Ametov AS; Head of Endocrinology, Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • Bazarova AV; Department of Internal Medicine #3, Astana Medical University (NpJSC "AMU"), 49A Beybitshilik Street, Nur-Sultan City, Kazakhstan.
  • Ebrahimi F; Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel, Switzerland.
  • Fasching P; Division of Gastroenterology, University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital, Basel, Switzerland.
  • Janez A; 5th Medical Department With Endocrinology, Rheumatology and Acute Geriatrics, Vienna Health Association Clinic Ottakring, 37 Montleartstraße, 1160, Vienna, Austria.
  • Kempler P; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, 7 Zaloska Cesta, 1000, Ljubljana, Slovenia.
  • Konrade I; Department of Internal Medicine and Oncology, Semmelweis University, 2/a Korányi Sándor Utca, Budapest, 1083, Hungary.
  • Lalic NM; Riga Stradins University, Riga, Latvia.
  • Mankovsky B; Riga East Clinical Hospital, Riga, Latvia.
  • Martinka E; Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Rahelic D; Department of Diabetology, National Medical Academy for Postgraduate Education, Kiev, Ukraine.
  • Serafinceanu C; National Institute of Endocrinology and Diabetology, Lubochna, Slovak Republic.
  • Skrha J; Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia.
  • Tankova T; School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Visockiene Z; Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Cardiovasc Diabetol ; 19(1): 185, 2020 10 23.
Article en En | MEDLINE | ID: mdl-33097060
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glucemia / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Control Glucémico / Enfermedades Renales Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glucemia / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Control Glucémico / Enfermedades Renales Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria